Stonnington Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Stonnington Group’s Portfolio BMRN Stock Details BMRN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$895K	Buy
2022 Q4	$847K	Sell
2022 Q3	$698K	Buy
2022 Q2	$371K	Buy
2022 Q1	$250K	Buy
2021 Q4	–	Sell
2021 Q3	$451K	Buy